Cisatracurium IV

Loading...

References

  1. NA. EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease.. Journal of hepatology, 2025
  2. Karen Pedersen. Peri-operative hypersensitivity reactions to neuromuscular blocking drugs in New Zealand 2013-2019: a retrospective observational study.. Anaesthesia, 2025
  3. Veerle Bijkerk. Residual neuromuscular block in the postanaesthesia care unit: a single-centre prospective observational study and systematic review.. British journal of anaesthesia, 2025
  4. Michael Brunini. Heterogenous treatment effect of neuromuscular blocking agents for moderate-to-severe ARDS: a post hoc Markov model re-analysis of the ACURASYS trial.. Intensive care medicine, 2025
  5. Nida Qadir. An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline.. American journal of respiratory and critical care medicine, 2024
  6. Siyuan Liu. Does deep neuromuscular blockade provide improved perioperative outcomes in adult patients? A systematic review and meta-analysis of randomized controlled trials. PLOS ONE, 2023
  7. W. Chang. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials. Critical Care, 2020
  8. A. Hristovska. The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta‐analysis and trial sequential analysis. Anaesthesia, 2018
  9. I. Song. Timing of reversal with respect to three nerve stimulator end‐points from cisatracurium‐induced neuromuscular block. Anaesthesia, 2015
  10. M. Burmester. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit. Intensive Care Medicine, 2005
  11. Reference - 10.1378/chest.126.4.1267